๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Genetic toxicology studies with glutaraldehyde

โœ Scribed by Jane S. Vergnes; Bryan Ballantyne


Publisher
John Wiley and Sons
Year
2002
Tongue
English
Weight
167 KB
Volume
22
Category
Article
ISSN
0260-437X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

Glutaraldehyde (GA; CAS no. 111โ€30โ€8) has a wide spectrum of industrial, scientific and biomedical applications, with a potential for human exposure particularly in its biocidal applications. The likelihood for genotoxic effects was investigated in vitro and in vivo. A Salmonella typhimurium reverse mutation assay showed no evidence for mutagenic activity with strains TA98, TA1535, TA1537 and TA1538, with or without metabolic activation. However, there was a weak mutagenic response (1.9โ€“2.3โ€fold at the highest nonโ€toxic concentration) with TA100 in the presence of metabolic activation. In a Chinese hamster ovary (CHO) forward gene mutation assay (HGPRT locus) there were no consistent, statistically significant, reproducible or dosageโ€related increases in the frequency of 6โ€thioguanine resistant cells. There were no reproducible or dosageโ€related increases in sister chromatid exchanges in an in vitro test in CHO cells. An in vitro cytogenetics study in CHO cells showed no evidence for an increase in chromosomal aberrations on treatment with GA, either in the presence or absence of metabolic activation. In vivo, a mouse peripheral blood micronucleus test showed no increase in micronucleated polychromatophils at sampling times of 30, 48 and 72 h after acute gavage dosing with GA at 40, 80 and 125 mg kg^โˆ’1^ (corresponding to 25, 50 and 85% of the LD~50~). The absence of an in vivo clastogenic potential was confirmed by no increase in chromosomal aberrations in a rat bone marrow cytogenetics study with sampling at 12, 24 and 48 h after acute gavage dosing with GA (12.5, 30 or 60 mg kg^โˆ’1^ with males, and 7.5, 20 or 40 mg kg^โˆ’1^ with females). Thus, in this series of tests, GA produced genotoxic effects in vitro only in a bacterial reverse mutation assay with no evidence for in vivo genotoxicity. Copyright ยฉ 2002 John Wiley & Sons, Ltd.


๐Ÿ“œ SIMILAR VOLUMES


Genetic toxicology studies with a tumor
โœ Y. Oshiro; C. E. Piper; M. L. Garriott; P. S. Balwierz; S. G. Soelter; E. Rohrba ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 923 KB

## Abstract A diuretic antihypertensive agent, SCโ€33643 (8โ€(2โ€ethoxyethyl)โ€7โ€phenylโ€[1,2,4]triazolo[4,3โ€c]pyrimidineโ€5โ€amine, also known as bemitradine), was tested in the Ames test, in the mouse lymphoma TK^ยฑ^ mutation assay, in the Chinese hamster ovary cell hypoxanthine guanine phosphoribosyl tr

In vitro and in vivo genetic toxicology
โœ Bryan Ballantyne; Jane S. Vergnes ๐Ÿ“‚ Article ๐Ÿ“… 2001 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 152 KB

## Abstract Diethylene glycol monohexyl ether (DEGHE; CAS no. 112โ€59โ€4), an industrial chemical, was investigated for the potential to produce genotoxic effects using three __in vitro__ and two __in vivo__ tests. No mutagenic activity occurred in either the absence or presence of metabolic activati

Toxicological studies with sisomicin
โœ K. Hoffmann; G. Luckhaus ๐Ÿ“‚ Article ๐Ÿ“… 1979 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 278 KB
Toxicology studies with a stable intrave
โœ J. A. Anderson; E. J. McGuire; J. R. Watkins; J. E. Fitzgerald; F. A. de la Igle ๐Ÿ“‚ Article ๐Ÿ“… 1983 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 438 KB

The preclinical toxicologic profile of Nitrostat, a stable parenteral formulation of nitroglycerin, was determined in mice, rats, rabbits and dogs. Single-dose i.v. studies in rodents yielded LD50 values of 17.3 and 18.2 mg kg-1 in male and female mice, and 24.4 and 23.2 mg kg-1 in male and female r